$NG
NOVAGOLD RESOURCES INC Stock $ng

$ng Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000117184324001819 Filed on April 03, 2024

Income Statement

Concept	2024 Q1
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.253M
YoY Change	11.54%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.000K
YoY Change	500.0%
% of Gross Profit
Operating Expenses	$6.259M
YoY Change	-37.92%
Operating Profit	-$9.220M
YoY Change	-8.55%
Interest Expense	-$4.702M
YoY Change	-18.23%
% of Operating Profit
Other Income/Expense, Net	$0.00
YoY Change	-100.0%
Pretax Income	-$10.22M
YoY Change	-3.46%
Income Tax	$100.0K
% Of Pretax Income
Net Earnings	-$10.32M
YoY Change	-3.2%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.03
Diluted Earnings Per Share	-$0.03
COMMON SHARES
Basic Shares Outstanding	334.4M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$117.5M
YoY Change	1.16%
Cash & Equivalents	$37.50M
Short-Term Investments	$80.00M
Other Short-Term Assets	$853.0K
YoY Change	-64.56%
Inventory
Prepaid Expenses	$853.0K
Receivables	$1.352M
Other Receivables	$184.0K
Total Short-Term Assets	$119.9M
YoY Change	-16.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$846.0K
YoY Change	-7.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.146M
YoY Change	-15.16%
Other Assets	$3.259M
YoY Change	7.27%
Total Long-Term Assets	$6.992M
YoY Change	-14.26%
TOTAL ASSETS
Total Short-Term Assets	$119.9M
Total Long-Term Assets	$6.992M
Total Assets	$126.9M
YoY Change	-16.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$568.0K
YoY Change	10.29%
Accrued Expenses	$1.102M
YoY Change	36.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.833M
YoY Change	-25.91%
LONG-TERM LIABILITIES
Long-Term Debt	$140.3M
YoY Change	10.83%
Other Long-Term Liabilities	$823.0K
YoY Change	-13.73%
Total Long-Term Liabilities	$141.2M
YoY Change	14697.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.833M
Total Long-Term Liabilities	$141.2M
Total Liabilities	$143.0M
YoY Change	9.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.070B
YoY Change	2.3%
Common Stock	$1.988B
YoY Change	0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$16.12M
YoY Change
Total Liabilities & Shareholders Equity	$126.9M
YoY Change	-16.17%

Cashflow Statement

Concept	2024 Q1
OPERATING ACTIVITIES
Net Income	-$10.32M
YoY Change	-3.2%
Depreciation, Depletion And Amortization	$6.000K
YoY Change	500.0%
Cash From Operating Activities	-$5.374M
YoY Change	19.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$2.880M
YoY Change	-44.49%
Cash From Investing Activities	-$2.880M
YoY Change	-44.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-5.374M
Cash From Investing Activities	-2.880M
Cash From Financing Activities	0.000
Net Change In Cash	-8.254M
YoY Change	-14.74%
FREE CASH FLOW
Cash From Operating Activities	-$5.374M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	404000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3906000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	136748000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	859000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	141513000	usd
CY2024Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	743000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45749000	usd
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001173420
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	703000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2799000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1988221000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89747000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2069629000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-24456000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-16117000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126884000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	-9220000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	-10082000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9220000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10082000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3597000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2944000	usd
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1551000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54161000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8223000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2409000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10318000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	15000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-16117000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1329000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1048000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	896000	usd
CY2024Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	0	usd
CY2023Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	217000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10218000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10584000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10318000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10659000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	15000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-101000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10303000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10760000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	334366
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	333948
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10318000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10659000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2961000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4475000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2409000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2161000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3597000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2944000	usd
CY2023Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	556000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	311000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	299000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	41000	usd
CY2024Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	-0	usd
CY2023Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	217000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	16000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	25000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2991000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2326000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5374000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4493000	usd
CY2024Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	3623000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	5744000	usd
CY2024Q1	ng	Proceeds From Sale Of Mineral Property ProceedsFromSaleOfMineralProperty	743000	usd
CY2023Q1	ng	Proceeds From Sale Of Mineral Property ProceedsFromSaleOfMineralProperty	556000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2880000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5188000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-40000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8246000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9721000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	63882000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37503000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29903000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2161000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10659000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-101000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21304000	usd
CY2024Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	1220000	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	99000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	853000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1125000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2389000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1470000	usd
CY2024Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	2413000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	2102000	usd
CY2024Q1	ng	Office Equipment OfficeEquipment	136000	usd
CY2023Q4	ng	Office Equipment OfficeEquipment	141000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3259000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3000000	usd
CY2024Q1	ng	Remediation Current Liabilities RemediationCurrentLiabilities	163000	usd
CY2023Q4	ng	Remediation Current Liabilities RemediationCurrentLiabilities	212000	usd
CY2024Q1	ng	Lease Obligations Current LeaseObligationsCurrent	182000	usd
CY2023Q4	ng	Lease Obligations Current LeaseObligationsCurrent	192000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	345000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	404000	usd
CY2024Q1	ng	Remediation Noncurrent Liabilities RemediationNoncurrentLiabilities	250000	usd
CY2023Q4	ng	Remediation Noncurrent Liabilities RemediationNoncurrentLiabilities	250000	usd
CY2024Q1	ng	Lease Obligations Noncurrent LeaseObligationsNoncurrent	573000	usd
CY2023Q4	ng	Lease Obligations Noncurrent LeaseObligationsNoncurrent	609000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	823000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	859000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2413000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2102000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2409000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2161000	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	2086000	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	1745000	usd
CY2024Q1	us-gaap	Other General Expense OtherGeneralExpense	735000	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	891000	usd
CY2024Q1	ng	Corporate Communications And Regulatory Expense CorporateCommunicationsAndRegulatoryExpense	358000	usd
CY2023Q1	ng	Corporate Communications And Regulatory Expense CorporateCommunicationsAndRegulatoryExpense	507000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	665000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	302000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	6000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6259000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5607000	usd
CY2024Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	743000	usd
CY2023Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	556000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	41000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	311000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	299000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1048000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	896000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2409000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2161000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7606200000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.59
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3088900000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.12
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	890000000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.67
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9805100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.07
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M4D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4532950000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.46
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y11M4D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.487	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.485	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0429	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0386	pure
CY2024Q1	ng	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.03	pure
CY2023Q1	ng	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.028	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.76
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.43
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	471000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1177000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6820000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	319300000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	9.92
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2173000000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.34
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	449000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	925000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	179000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-137000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-250000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1881000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1890000	usd
CY2024Q1	ng	Increase Decrease In Remediation Liability IncreaseDecreaseInRemediationLiability	-48000	usd
CY2023Q1	ng	Increase Decrease In Remediation Liability IncreaseDecreaseInRemediationLiability	-7000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2991000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2326000	usd
CY2024Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	429000	usd
CY2023Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	585000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	75000	usd

Files In Submission

Name	View Source	Status
0001171843-24-001819-index-headers.html	Edgar Link	pending
0001171843-24-001819-index.html	Edgar Link	pending
0001171843-24-001819.txt	Edgar Link	pending
0001171843-24-001819-xbrl.zip	Edgar Link	pending
ex_645226.htm	Edgar Link	pending
ex_645227.htm	Edgar Link	pending
ex_645228.htm	Edgar Link	pending
ex_645229.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ng-20240229.xsd	Edgar Link	pending
ng20240228_10q.htm	Edgar Link	pending
ng-20240229_cal.xml	Edgar Link	unprocessable
ng-20240229_def.xml	Edgar Link	unprocessable
ng-20240229_pre.xml	Edgar Link	unprocessable
ng-20240229_lab.xml	Edgar Link	unprocessable
ng20240228_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NG
NOVAGOLD RESOURCES INC Stock $ng

2024 Q1 Form 10-Q Financial Statement

#000117184324001819 Filed on April 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NG NOVAGOLD RESOURCES INC Stock $ng

2024 Q1 Form 10-Q Financial Statement

#000117184324001819 Filed on April 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NG
NOVAGOLD RESOURCES INC Stock $ng